Trials / Recruiting
RecruitingNCT04987086
68Ga-PSMA PET in the Renal Cell Carcinoma
A Prospective, Multicenter Study of Diagnostic Efficiency of 68Ga-PSMA PET in the Patients With Locally Advanced and Advanced Renal Cell Carcinoma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The primary research purpose is to evaluate the diagnostic efficacy of 68Ga-PSMA PET in metastatic lesions of locally advanced and advanced renal cell carcinoma, and to compare with that of enhanced CT. The second purpose is to evaluate whether 68Ga-PSMA PET can change the treatment decision of patients with locally advanced and advanced renal cell carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PSMA PET | PSMA PET may have influence on the clinical decision-making of the patients with renal cancer |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
- First posted
- 2021-08-03
- Last updated
- 2026-03-11
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04987086. Inclusion in this directory is not an endorsement.